All lobbying filings
TIBER CREEK GROUP
Lobbying for JAZZ PHARMACEUTICALS · ​Biopharmaceutical company.
Filing
Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 18, 2025
Income
$50,000.00
What the client paid this registrant for the period.
Client based in
California
Government bodies contacted
2
Lobbying activity
3
Issues related to the FDA and Health and Human Services pertaining to CBD policies; Issues related to the regulation of intoxifying hemp.
Issues related to cannabis research; Issues related to the FDA; Issues related to cannabis research at Health and Human Services.
Appropriations issues related to House Ag/FDA Appropriations pertaining to FDA enforcement of non-FDA approved, cannabis derived CBD products; Ag/ FDA amendment - technical correction to the 2026 Ag/ FDA appropriations bill related to hemp; Issues related to intoxifying hemp products.